{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:30:04Z","timestamp":1791423004907,"version":"4.3.3"},"reference-count":165,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The finding that some mAbs are antifungal suggests that antibody immunity may play a key role in the defense of the host against mycotic infections. The discovery of antibodies that guard against fungi is a significant advancement because it gives rise to the possibility of developing vaccinations that trigger protective antibody immunity. These vaccines might work by inducing antibody opsonins that improve the function of non-specific (such as neutrophils, macrophages, and NK cells) and specific (such as lymphocyte) cell-mediated immunity and stop or aid in eradicating fungus infections. The ability of antibodies to defend against fungi has been demonstrated by using monoclonal antibody technology to reconsider the function of antibody immunity. The next step is to develop vaccines that induce protective antibody immunity and to comprehend the mechanisms through which antibodies mediate protective effects against fungus.<\/jats:p>","DOI":"10.3390\/microorganisms11030671","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T02:30:45Z","timestamp":1678156245000},"page":"671","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antibodies to Combat Fungal Infections: Development Strategies and Progress"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-9847","authenticated-orcid":false,"given":"Ali A.","family":"Rabaan","sequence":"first","affiliation":[{"name":"Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia"},{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"},{"name":"Department of Public Health and Nutrition, The University of Haripur, Haripur 22610, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal H.","family":"Alfaraj","sequence":"additional","affiliation":[{"name":"Pediatric Department, Abqaiq General Hospital, First Eastern Health Cluster, Abqaiq 33261, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6861-6934","authenticated-orcid":false,"given":"Amer","family":"Alshengeti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah 41491, Saudi Arabia"},{"name":"Department of Infection Prevention and Control, Prince Mohammad Bin Abdulaziz Hospital, National Guard Health Affairs, Al-Madinah 41491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam","family":"Alawfi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah 41491, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alwarthan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashael","family":"Alhajri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9703-1177","authenticated-orcid":false,"given":"Amal H.","family":"Al-Najjar","sequence":"additional","affiliation":[{"name":"Drug & Poison Information Center, Pharmacy Department, Security Forces Hospital Program, Riyadh 11481, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-0642","authenticated-orcid":false,"given":"Mona A.","family":"Al Fares","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa A.","family":"Najim","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah 41411, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad A.","family":"Almuthree","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, King Abdullah Medical City, Makkah 43442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan T.","family":"AlShurbaji","sequence":"additional","affiliation":[{"name":"Outpatient Pharmacy, Dr. Sulaiman Alhabib Medical Group, Diplomatic Quarter, Riyadh 91877, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadwa S.","family":"Alofi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, King Fahad Hospital, Madinah 42351, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-9462","authenticated-orcid":false,"given":"Bashayer M.","family":"AlShehail","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buthina","family":"AlYuosof","sequence":"additional","affiliation":[{"name":"Directorate of Public Health, Dammam Network, Eastern Health Cluster, Dammam 31444, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam","family":"Alynbiawi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh 12231, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha A.","family":"Alzayer","sequence":"additional","affiliation":[{"name":"Parasitology Laboratory Department, Qatif Comprehensive Inspection Center, Qatif 31911, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2180-4158","authenticated-orcid":false,"given":"Nawal","family":"Al Kaabi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease, Sheikh Khalifa Medical City, Abu Dhabi 51900, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam A.","family":"Abduljabbar","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, Fakeeh College for Medical Science, Jeddah 21134, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakiyah A.","family":"Bukhary","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Fahad General Hospital, Jeddah 23325, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Bueid","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, King Faisal General Hospital, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40694-018-0054-5","article-title":"How a fungus shapes biotechnology: 100 years of Aspergillus niger research","volume":"5","author":"Cairns","year":"2018","journal-title":"Fungal Biol. Biotechnol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.copbio.2019.02.011","article-title":"Oleaginous yeast for biofuel and oleochemical production","volume":"57","author":"Spagnuolo","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/107555302320825066","article-title":"Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants","volume":"8","author":"Chang","year":"2002","journal-title":"J. Altern. Complement. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1753-4887.2009.00230.x","article-title":"Beta-glucans in higher fungi and their health effects","volume":"67","author":"Rop","year":"2009","journal-title":"Nutr. Rev."},{"key":"ref_5","first-page":"189","article-title":"Plants, polysaccharides, and the treatment and prevention of neoplasia","volume":"11","author":"Pelley","year":"2000","journal-title":"Crit. Rev. \u2122 Oncog."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Leal, F. (2019). Fungal Pathogenesis in Humans: The Growing Threat. Genes, 10.","DOI":"10.3390\/genes10020136"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.micro.55.1.743","article-title":"Aspects of fungal pathogenesis in humans","volume":"55","author":"Magee","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8164757","DOI":"10.1155\/2018\/8164757","article-title":"Dermatophytosis: Prevalence of dermatophytes and non-dermatophyte fungi from patients attending Arsho advanced medical laboratory, Addis Ababa, Ethiopia","volume":"2018","author":"Bitew","year":"2018","journal-title":"Dermatol. Res. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.apjtb.2017.01.019","article-title":"Nosocomial infections: Epidemiology, prevention, control and surveillance","volume":"7","author":"Khan","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/jam.15032","article-title":"A global view on fungal infections in humans and animals: Opportunistic infections and microsporidioses","volume":"131","author":"Gnat","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and multi-national prevalence of fungal diseases\u2014Estimate precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fmicb.2019.00214","article-title":"The still underestimated problem of fungal diseases worldwide","volume":"10","author":"Almeida","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_14","unstructured":"Darwin, J. (2015). Improving Outcomes for Patients with Fungal Infections across the World a Road Map for the Next Decade, Global Action Fund for Fungal Infections."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"a019273","DOI":"10.1101\/cshperspect.a019273","article-title":"The spectrum of fungi that infects humans","volume":"5","author":"Casadevall","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Fraser","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1473-3099(17)30303-1","article-title":"Fungal infections in HIV\/AIDS","volume":"17","author":"Limper","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","article-title":"Invasive fungal infections in patients with cancer in the Intensive Care Unit","volume":"39","author":"Sipsas","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Martinez, R. (2017). New trends in paracoccidioidomycosis epidemiology. J. Fungi, 3.","DOI":"10.3390\/jof3010001"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.4049\/jimmunol.1401940","article-title":"Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis","volume":"194","author":"Wharton","year":"2015","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s00018-020-03736-z","article-title":"Mechanisms of fungal dissemination","volume":"78","author":"Strickland","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/21505594.2015.1012981","article-title":"Candida albicans-epithelial interactions and pathogenicity mechanisms: Scratching the surface","volume":"6","author":"Moyes","year":"2015","journal-title":"Virulence"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/82_2018_114","article-title":"Histoplasma capsulatum: Mechanisms for pathogenesis","volume":"422","author":"Mittal","year":"2019","journal-title":"Fungal Physiol. Immunopathogenesis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","article-title":"Adaptive immune responses to Candida albicans infection","volume":"6","author":"Richardson","year":"2015","journal-title":"Virulence"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri1255","article-title":"Immunity to fungal infections","volume":"4","author":"Romani","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.4049\/jimmunol.177.5.3303","article-title":"Characterization of the Histoplasma capsulatum-induced granuloma","volume":"177","author":"Heninger","year":"2006","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10156-005-0387-X","article-title":"Granuloma and cryptococcosis","volume":"11","author":"Shibuya","year":"2005","journal-title":"J. Infect. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.micinf.2004.05.013","article-title":"Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages","volume":"6","author":"Netea","year":"2004","journal-title":"Microbes Infect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.chom.2011.04.007","article-title":"A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus","volume":"9","author":"Lee","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_32","first-page":"e74","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ancuta","year":"2010","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1002\/eji.201141418","article-title":"The classical CD14++ CD16\u2212 monocytes, but not the patrolling CD14+ CD16+ monocytes, promote Th17 responses to Candida albicans","volume":"41","author":"Smeekens","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2013.07.006","article-title":"Natural killer cell biology: An update and future directions","volume":"132","author":"Campbell","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/infdis\/jit574","article-title":"Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity","volume":"209","author":"Voigt","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/infdis\/jiq062","article-title":"Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia","volume":"203","author":"Schmidt","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.micinf.2006.12.003","article-title":"Role of interferon-\u03b3 in V\u03b114+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs","volume":"9","author":"Nakamatsu","year":"2007","journal-title":"Microbes Infect."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.chom.2011.09.011","article-title":"Innate recognition of cell wall \u03b2-glucans drives invariant natural killer T cell responses against fungi","volume":"10","author":"Cohen","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: Data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/13693780500402138","article-title":"Prospects of vaccines for medically important fungi","volume":"43","author":"Feldmesser","year":"2005","journal-title":"Sabouraudia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/AAC.00365-13","article-title":"Identification and mechanism of action of the plant defensin NaD1 as a new member of the antifungal drug arsenal against Candida albicans","volume":"57","author":"Hayes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.coi.2012.04.007","article-title":"Immunity to fungi","volume":"24","author":"Hohl","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.4049\/jimmunol.174.12.7920","article-title":"Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection","volume":"174","author":"Lindell","year":"2005","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Nanjappa, S.G., Heninger, E., W\u00fcthrich, M., Gasper, D.J., and Klein, B.S. (2012). Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002771"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.immunol.20.100301.064833","article-title":"Origins and Functions of B-1 Cells","volume":"20","author":"Berland","year":"2002","journal-title":"Annu. Rev. Immunol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.coi.2006.07.010","article-title":"B-1 B cells: Development, selection, natural autoantibody and leukemia","volume":"18","author":"Hardy","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-3083.2003.01314.x","article-title":"Natural autoantibodies as tools to predict the outcome of immune response?","volume":"58","author":"Kohler","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/srep02271","article-title":"Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV","volume":"3","author":"Zhou","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2004.02.004","article-title":"Polyreactivity of antibody molecules","volume":"25","author":"Notkins","year":"2004","journal-title":"Trends Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nri2849","article-title":"The importance of natural IgM: Scavenger, protector and regulator","volume":"10","author":"Ehrenstein","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","article-title":"Natural autoantibodies","volume":"7","author":"Coutinho","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.femsim.2004.03.012","article-title":"Antibody response to Candida albicans cell wall antigens","volume":"41","author":"Casanova","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jlb.44.5.422","article-title":"Nonspecific and Candida-Specific Immune Responses in Mice Suppressed by Chronic Administration of Anti-\u03bc","volume":"44","author":"Kuruganti","year":"1988","journal-title":"J. Leukoc. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1128\/IAI.66.12.5771-5776.1998","article-title":"A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection","volume":"66","author":"Han","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/iai.60.11.4534-4541.1992","article-title":"Protective murine monoclonal antibodies to Cryptococcus neoformans","volume":"60","author":"Mukherjee","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/eji.200323790","article-title":"A role for antibodies in the generation of memory antifungal immunity","volume":"33","author":"Montagnoli","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1462-5822.2006.00786.x","article-title":"Host defence against C. albicans infections in IgH transgenic mice with VH derived from a natural anti-keratin antibody","volume":"9","author":"Li","year":"2007","journal-title":"Cell. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tian, R., Fu, M., Zhang, Z., Ren, J., An, J., Liu, Y., and Li, W. (2013). In situ IgM production and clonal expansion of B-1 cells in peritoneal cavity promote elimination of C. albicans infection in IgH transgenic mice with VH derived from a natural antibody. PLoS ONE, 8.","DOI":"10.1371\/annotation\/bedab014-d393-4fad-aa07-0df1efb59038"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/eji.200323848","article-title":"The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3-mediated interactions","volume":"33","author":"Zaragoza","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/IAI.70.5.2598-2604.2002","article-title":"Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3","volume":"70","author":"Shapiro","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Van Spriel, A.B., Sofi, M., Gartlan, K.H., van der Schaaf, A., Verschueren, I., Torensma, R., Raymakers, R.A., Loveland, B.E., Netea, M.G., and Adema, G.J. (2009). The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000338"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/iai.58.3.639-645.1990","article-title":"Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody","volume":"58","author":"Miller","year":"1990","journal-title":"Infect. Immun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/iai.51.2.556-562.1986","article-title":"Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans","volume":"51","author":"Nabavi","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1566524054022558","article-title":"Protective antifungal yeast killer toxin-like antibodies","volume":"5","author":"Magliani","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: The silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb. Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fcimb.2016.00142","article-title":"Anti-immune strategies of pathogenic fungi","volume":"6","author":"Marcos","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2018.03.003","article-title":"Pattern recognition receptors in fungal immunity","volume":"89","author":"Patin","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0002-9343(87)90388-3","article-title":"Disseminated cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions","volume":"82","author":"Gupta","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_71","first-page":"686","article-title":"Bruton\u2019s agamma globulinaemia in a child presenting with cryptococcal, empyemia thoracis and periauricular pyogenic abscess","volume":"36","author":"Wahab","year":"1995","journal-title":"Singap. Med. J."},{"key":"ref_72","first-page":"603","article-title":"Hypogammaglobulinemia as predisposing factor for Cryptococcus neoformans infection: Report of two cases","volume":"33","author":"Pires","year":"2000","journal-title":"Rev. Da Soc. Bras. De Med. Trop."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI3409","article-title":"Absence of IgD-CD27 (+) memory B cell population in X-linked hyper-IgM syndrome","volume":"102","author":"Agematsu","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cid\/cir756","article-title":"Cryptococcus gattii infection in healthy hosts: A sentinel for subclinical immunodeficiency?","volume":"54","author":"Marr","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/314953","article-title":"Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection","volume":"180","author":"Abadi","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2249.1995.tb05568.x","article-title":"Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV\u2212 individuals","volume":"99","author":"Deshaw","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0966-842X(01)02134-5","article-title":"Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens","volume":"9","author":"Pirofski","year":"2001","journal-title":"Trends Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.4049\/jimmunol.0901638","article-title":"The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans","volume":"184","author":"Subramaniam","year":"2010","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1084\/jem.20100034","article-title":"Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina","volume":"207","author":"Rapaka","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e00265-13","DOI":"10.1128\/mBio.00265-13","article-title":"X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans infection","volume":"4","author":"Szymczak","year":"2013","journal-title":"MBio"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","article-title":"A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities","volume":"71","author":"Moragues","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Torosantucci, A., Chiani, P., Bromuro, C., De Bernardis, F., Palma, A.S., Liu, Y., Mignogna, G., Maras, B., Colone, M., and Stringaro, A. (2009). Protection by anti-\u03b2-glucan antibodies is associated with restricted \u03b2-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005392"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1462-5822.2008.01152.x","article-title":"Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation","volume":"10","author":"Alvarez","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00436540","article-title":"Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice","volume":"91","author":"Maiti","year":"1985","journal-title":"Mycopathologia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/infdis\/164.5.936","article-title":"Acquired immunity to systemic candidiasis in immunodeficient mice","volume":"164","author":"Cantorna","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/iai.59.6.2116-2119.1991","article-title":"Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome","volume":"59","author":"Narayanan","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0090-1229(84)90308-8","article-title":"Immunodeficient CBA\/N mice respond effectively to Candida albicans","volume":"33","author":"Carrow","year":"1984","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_89","first-page":"316","article-title":"Studies of the role of B-cells in the resistance of mice to experimental candidiasis","volume":"266","author":"Sinha","year":"1987","journal-title":"Zent. F\u00fcr Bakteriol. Mikrobiol. Und Hygiene. Ser. A Med. Microbiol. Infect. Dis. Virol. Parasitol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-013-9671-y","article-title":"B cell-deficient mice display enhanced susceptibility to Paracoccidioides brasiliensis infection","volume":"176","author":"Panagio","year":"2013","journal-title":"Mycopathologia"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1389557516666160118112103","article-title":"The mechanistic targets of antifungal agents: An overview","volume":"16","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","article-title":"Fungal vaccines, mechanism of actions and immunology: A comprehensive review","volume":"109","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis","volume":"194","author":"Spellberg","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"Amacker","year":"2012","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","article-title":"The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis","volume":"74","author":"Ibrahim","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/649901","article-title":"Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein","volume":"201","author":"Baquir","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","article-title":"Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination","volume":"183","author":"Bozza","year":"2009","journal-title":"J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CVI.00480-08","article-title":"Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis","volume":"16","author":"Saville","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/pmic.200701056","article-title":"Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice","volume":"8","author":"Nombela","year":"2008","journal-title":"Proteomics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/iai.51.2.668-674.1986","article-title":"Evidence for macrophage-mediated protection against lethal Candida albicans infection","volume":"51","author":"Bistoni","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actbio.2016.05.001","article-title":"Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis","volume":"39","author":"Carneiro","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/314779","article-title":"Candida albicans mannan extract\u2014Protein conjugates induce a protective immune response against experimental candidiasis","volume":"179","author":"Han","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","article-title":"A \u03b2-glucan-conjugate vaccine and anti-\u03b2-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique","volume":"28","author":"Pietrella","year":"2010","journal-title":"Vaccine"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.vaccine.2008.11.030","article-title":"Anti-\u03b2-glucan antibodies in healthy human subjects","volume":"27","author":"Chiani","year":"2009","journal-title":"Vaccine"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","article-title":"Beta-glucan-CRM197 conjugates as candidates antifungal vaccines","volume":"28","author":"Bromuro","year":"2010","journal-title":"Vaccine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.intimp.2007.05.014","article-title":"Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate","volume":"7","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Cutler, J.E., Corti, M., Lambert, P., Ferris, M., and Xin, H. (2011). Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022030"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/CVI.05215-11","article-title":"Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis","volume":"18","author":"Xin","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/IAI.67.2.826-833.1999","article-title":"Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT (R192G), against systemic candidiasis","volume":"67","author":"Cheng","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Luo, G., Ibrahim, A.S., French, S.W., Edwards, J.E., and Fu, Y. (2011). Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025909"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining \u03b2-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","article-title":"T cell vaccination in mice with invasive pulmonary aspergillosis","volume":"165","author":"Cenci","year":"2000","journal-title":"J. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/IAI.01311-10","article-title":"CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine","volume":"79","author":"Bagramyan","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/342509","article-title":"Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis","volume":"186","author":"Ito","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1128\/IAI.00815-06","article-title":"Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis","volume":"74","author":"Ito","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/mmy\/myt015","article-title":"Protection against experimental aspergillosis by heat-killed yeast is not antibody dependent","volume":"52","author":"Clemons","year":"2014","journal-title":"Sabouraudia"},{"key":"ref_119","first-page":"5881","article-title":"Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S1286-4579(02)00007-2","article-title":"Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants","volume":"4","author":"Bozza","year":"2002","journal-title":"Microbes Infect."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: Implications for vaccine development in immune-deficient hosts","volume":"197","author":"Filutowicz","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/S0264-410X(00)00074-8","article-title":"DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from Paracoccidioides brasiliensis","volume":"18","author":"Pinto","year":"2000","journal-title":"Vaccine"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Assis-Marques, M.A., Oliveira, A.F., Ruas, L.P., Reis, T.F.d., Roque-Barreira, M.C., and Coelho, P.S.R. (2015). Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120201"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/IAI.01470-08","article-title":"Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin","volume":"77","author":"Braga","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Fernandes, V.C., Martins, E.M., Boeloni, J.N., Coitinho, J.B., Serakides, R., and Goes, A.M. (2011). Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017885"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/IAI.00753-07","article-title":"Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection","volume":"76","author":"Gomez","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.vaccine.2009.11.062","article-title":"HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis","volume":"28","author":"Ribeiro","year":"2010","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","article-title":"Evaluation of Cryptococcus neoformans galactoxylomannan\u2013protein conjugate as vaccine candidate against murine cryptococcosis","volume":"29","author":"Chow","year":"2011","journal-title":"Vaccine"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/CVI.00036-11","article-title":"Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice","volume":"18","author":"Wozniak","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3389\/fmicb.2015.00836","article-title":"Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: Potential applications for vaccine development","volume":"6","author":"Rella","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/520536","article-title":"Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein","volume":"196","author":"Specht","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.vaccine.2005.02.029","article-title":"Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures","volume":"23","author":"Oscarson","year":"2005","journal-title":"Vaccine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-\u03b2-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1172\/JCI26306","article-title":"CD4+ T cell\u2013independent DNA vaccination against opportunistic infections","volume":"115","author":"Zheng","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1139\/w11-023","article-title":"Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats","volume":"57","author":"Feng","year":"2011","journal-title":"Can. J. Microbiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0264-410X(98)80113-8","article-title":"Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response","volume":"16","author":"Theus","year":"1998","journal-title":"Vaccine"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/iai.4.2.116-125.1971","article-title":"Characterization of antigens from the yeast phase of Histoplasma capsulatum","volume":"4","author":"Garcia","year":"1971","journal-title":"Infect. Immun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/iai.15.3.789-795.1977","article-title":"Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum","volume":"15","author":"Tewari","year":"1977","journal-title":"Infect. Immun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","article-title":"Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum","volume":"112","author":"Nosanchuk","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/IAI.70.7.3759-3767.2002","article-title":"Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum","volume":"70","author":"Deepe","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/iai.59.12.4459-4464.1991","article-title":"Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells","volume":"59","author":"Gomez","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/iai.60.7.2565-2571.1992","article-title":"An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice","volume":"60","author":"Gomez","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/500244","article-title":"Pulmonary V\u03b24+ T Cells from Histoplasma capsulatum\u2013Infected Mice Respond to a Homologue of Sec31 That Confers a Protective Response","volume":"193","author":"Scheckelhoff","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1128\/IAI.69.5.3128-3134.2001","article-title":"Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis","volume":"69","author":"Deepe","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Cheah, H.-L., Lim, V., and Sandai, D. (2014). Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095951"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-4157(86)90002-X","article-title":"How do the polyene macrolide antibiotics affect the cellular membrane properties?","volume":"864","author":"Bolard","year":"1986","journal-title":"Biochim. Et Biophys. Acta (BBA)-Rev. Biomembr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00239-011-9462-3","article-title":"Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: Potential antifungal targets","volume":"73","author":"Villa","year":"2011","journal-title":"J. Mol. Evol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/28.suppl_B.27","article-title":"Amphotericin B: An introduction","volume":"28","author":"Warnock","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.46.8.2704-2707.2002","article-title":"Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis","volume":"46","author":"Delmas","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fphar.2019.00080","article-title":"The yin and yang of current antifungal therapeutic strategies: How can we harness our natural defenses?","volume":"10","author":"Guerriero","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/AAC.40.10.2237","article-title":"In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum","volume":"40","author":"Hata","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/jb.173.10.3101-3108.1991","article-title":"The phosphoinositol sphingolipids of Saccharomyces cerevisiae are highly localized in the plasma membrane","volume":"173","author":"Patton","year":"1991","journal-title":"J. Bacteriol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fmicb.2011.00212","article-title":"Fungal glucosylceramides: From structural components to biologically active targets of new antimicrobials","volume":"2","author":"Nimrichter","year":"2011","journal-title":"Front. Microbiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0005-2736(95)00133-N","article-title":"The yeast plasma membrane proton pumping ATPase is a viable antifungal target. I. Effects of the cysteine-modifying reagent omeprazole","volume":"1239","author":"Monk","year":"1995","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin antifungal drugs in fungal infections","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7164\/antibiotics.45.618","article-title":"Deoxymulundocandin-a new echinocandin type antifungal antibiotic","volume":"45","author":"Mukhopadhyay","year":"1992","journal-title":"J. Antibiot."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/AAC.00432-11","article-title":"Discovery of a novel class of orally active antifungal \u03b2-1, 3-d-glucan synthase inhibitors","volume":"55","author":"Walker","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials","volume":"209","author":"Shubitz","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1021\/jo960769n","article-title":"Arthrichitin. A new cell wall active metabolite from Arthrinium phaeospermum","volume":"61","author":"Vijayakumar","year":"1996","journal-title":"J. Org. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1128\/AAC.36.10.2131","article-title":"Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery","volume":"36","author":"Fostel","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.39.3.586","article-title":"Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans","volume":"39","author":"Fostel","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/mmy\/myw081","article-title":"Aspergillus vaccines: Hardly worth studying or worthy of hard study?","volume":"55","author":"Levitz","year":"2016","journal-title":"Sabouraudia"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/3\/671\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:49:06Z","timestamp":1760122146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/3\/671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":165,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["microorganisms11030671"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11030671","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}